Human Genome Sciences, Inc. (HGSI) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Human Genome Sciences, Inc. (HGSI)

An SI Board Since March 1996

Posts	SubjectMarks	Bans	Symbol
1127	105	0	HGSI

Emcee: Jeffrey Ogbar	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
77	I do believe that HGSI has been profitable recently do to roylaty income. Davi	David Bogdanoff	-	3/4/1997
76	It seems to me the market is uneasy about valuation of both HGSI and INCY, but	Boyce Burge	-	3/4/1997
75	HGSI mainly wants to be a drug company and use the genomic info to cure disease	Rocketman	-	3/4/1997
74	Thanks for the comments. I believe this is an important consideration relative	Troll_29	-	3/2/1997
73	The questions you ask regarding patents would really take an expert to answer.	David Bogdanoff	-	3/2/1997
72	The recent understanding between the US and various other countries regarding p	Troll_29	-	3/2/1997
71	Very interesting article on HGSI in the April, 1966, issue 0f Individual Invest	David Bogdanoff	-	3/2/1997
70	Troll, I don't know whether you are correct or not but I will find out. On	Vector1	-	3/2/1997
69	Vector: I understand the Clinton Administration cut or eliminated funding for	Troll_29	-	3/2/1997
68	Miles, its no great secret that investment banks try to price secondary offerin	Vector1	-	3/1/1997
67	Brokers may have a vested interested to slightly under-price a NEW issue, but w	Miles Rhyne Hoffman, CFA	-	3/1/1997
66	Depends on the price the shares go out at and the return the company generates	Vector1	-	2/28/1997
65	will the 3m share offering dilute the value of the shares currently outstanding	kas1	-	2/28/1997
64	Thanks for the clarification Boyce. I wonder why Merck should be so generous a	David Bogdanoff	-	2/28/1997
63	The ESTs are just the partial sequences of genes that everyone makes from mRNA	Boyce Burge	-	2/28/1997
62	Thanks for the explanation. What exactly are ESTs that U Washington are making	David Bogdanoff	-	2/28/1997
61	It seems to me the point is that genes are only patentable if you can describe	Boyce Burge	-	2/27/1997
60	Amen to full testing. Inadequate testing is a chronic weak point for startup b	David Bogdanoff	-	2/27/1997
59	My point was that I do not believe the people on this thread who assert that th	Troll_29	-	2/26/1997
58	HGSI has patents filed on over 200 cDNA sequences and accounts fo 20% of all ge	Vector1	-	2/26/1997
57	Even if their database became obsolete, would that reduce the value of their pa	Troll_29	-	2/25/1997
56	Why would the U of Washington study make hgsi's database obsolete. There w	David Bogdanoff	-	2/25/1997
55	Thanks for the info! - Jeff	FIFO_kid2	-	2/25/1997
54	i heard an offhand comment that merck is funding a univeristy of washington stu	kas1	-	2/25/1997
53	This thread needs to be revived !! This is the ONLY initial stage company I ca	FIFO_kid2	-	2/25/1997

Go to reply# or date (mm/dd/yy):